(R,S)-Indatraline

(R,S)-Indatraline

SCHEMBL31307192

CN[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 1.00
SLC6A4 P31645 10/20 1.00
SLC6A3 Q01959 10/20 1.00
CYP3A4 P08684 5/20 1.00
TP53 P04637 4/20 1.00
CYP1A2 P05177 3/20 1.00
CYP2C19 P33261 3/20 1.00
MAPK1 P28482 3/20 1.00
NPC1 O15118 2/20 1.00
CYP2D6 P10635 2/20 1.00
MTOR P42345 2/20 1.00
RAB9A P51151 2/20 1.00
TSHR P16473 2/20 1.00
NFKB1 P19838 2/20 1.00
THPO P40225 2/20 1.00
CYP2C9 P11712 1/20 1.00
MEN1 O00255 5/20 0.97
KMT2A Q03164 5/20 0.97
MAPT P10636 3/20 0.97
GMNN O75496 2/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indatraline SCHEMBL585770 1.00 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Indatraline SCHEMBL29516308 1.00 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Indatraline SCHEMBL11128740 1.00 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Indatraline SCHEMBL9252635 1.00 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
(R,S)-Indatraline SCHEMBL9252640 1.00 SLC6A2 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
(R,S)-Indatraline SCHEMBL29516529 0.98 MEN1 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Indatraline SCHEMBL467134 0.98 MEN1 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Indatraline SCHEMBL5436564 0.98 MEN1 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Sertraline SCHEMBL3947169 0.87 MEN1 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53
Sertraline SCHEMBL137619 0.87 MEN1 (1.00) SLC6A2SLC6A4SLC6A3CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025003193-A1 SERTRALINE AND INDATRALINE FOR DISRUPTING INTRACELLULAR CHOLESTEROL TRAFFICKING AND SUBSEQUENTLY INDUCING LYSOSOMAL DAMAGE AND ANTI-TUMOR IMMUNITY Institut National de la Santé et de la Recherche Médicale (FR) 2025-01-02 WO disclosed